Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pierre Wolkenstein

Showing results (141-150 of 230) with videos related to

Pageof 23
Sort By:
Journal of the European Academy of Dermatology and Venereology : JEADV|May 20, 2026
Outcome measures for cutaneous neurofibromas in NF1: Insights from an international studyChristina Bergqvist, Laura Fertitta, Soulef Mehri, et al.
Orphanet Journal of Rare Diseases|July 15, 2011
At-risk phenotype of neurofibromatose-1 patients: a multicentre case-control studyEmilie Sbidian, Sylvie Bastuji-Garin, Laurence Valeyrie-Allanore, et al.
Critical Care Medicine|August 31, 2013
Acute respiratory failure in patients with toxic epidermal necrolysis: clinical features and factors associated with mechanical ventilationNicolas de Prost, Armand Mekontso-Dessap, Laurence Valeyrie-Allanore, et al.
Journal of the National Cancer Institute|September 18, 2015
Prognostic Value of 25-hydroxyvitamin D3 Levels at Diagnosis and During Follow-up in Melanoma PatientsPhilippe Saiag, Philippe Aegerter, Dominique Vitoux, et al.
JAMA Dermatology|February 12, 2015
Stevens-Johnson syndrome and toxic epidermal necrolysis: ear, nose, and throat description at acute stage and after remissionEmilie Bequignon, Tu Anh Duong, Emilie Sbidian, et al.
Orphanet Journal of Rare Diseases|September 5, 2012
Clinical characteristics predicting internal neurofibromas in 357 children with neurofibromatosis-1: results from a cross-selectional studyEmilie Sbidian, Smaïl Hadj-Rabia, Vincent M Riccardi, et al.
Medicine|January 16, 2010
Bacteremia in Stevens-Johnson syndrome and toxic epidermal necrolysis: epidemiology, risk factors, and predictive value of skin culturesNicolas de Prost, Saskia Ingen-Housz-Oro, Tu Anh Duong, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine|June 18, 2023
Topical delivery of mitogen-activated protein kinase inhibitor binimetinib prevents the development of cutaneous neurofibromas in neurofibromatosis type 1 mutant miceFanny Coulpier, Pernelle Pulh, Layna Oubrou, et al.
Melanoma Research|April 2, 2004
Cutaneous malignant melanoma and neurofibromatosis type 1Bernard Guillot, Sophie Dalac, Michele Delaunay, et al.
Dermatology (Basel, Switzerland)|April 15, 2015
Positive Direct Immunofluorescence Is of Better Value than ELISA-BP180 and ELISA-BP230 Values for the Prediction of Relapse after Treatment Cessation in Bullous Pemphigoid: A Retrospective Study of 97 PatientsSaskia Ingen-Housz-Oro, Julie Plée, Thibaut Belmondo, et al.
Pageof 23

Showing results (141-150 of 230) with videos related to

Sort By:
Pageof 23
Journal of the European Academy of Dermatology and Venereology : JEADV|May 20, 2026
Outcome measures for cutaneous neurofibromas in NF1: Insights from an international studyChristina Bergqvist, Laura Fertitta, Soulef Mehri, et al.
Orphanet Journal of Rare Diseases|July 15, 2011
At-risk phenotype of neurofibromatose-1 patients: a multicentre case-control studyEmilie Sbidian, Sylvie Bastuji-Garin, Laurence Valeyrie-Allanore, et al.
Critical Care Medicine|August 31, 2013
Acute respiratory failure in patients with toxic epidermal necrolysis: clinical features and factors associated with mechanical ventilationNicolas de Prost, Armand Mekontso-Dessap, Laurence Valeyrie-Allanore, et al.
Journal of the National Cancer Institute|September 18, 2015
Prognostic Value of 25-hydroxyvitamin D3 Levels at Diagnosis and During Follow-up in Melanoma PatientsPhilippe Saiag, Philippe Aegerter, Dominique Vitoux, et al.
JAMA Dermatology|February 12, 2015
Stevens-Johnson syndrome and toxic epidermal necrolysis: ear, nose, and throat description at acute stage and after remissionEmilie Bequignon, Tu Anh Duong, Emilie Sbidian, et al.
Orphanet Journal of Rare Diseases|September 5, 2012
Clinical characteristics predicting internal neurofibromas in 357 children with neurofibromatosis-1: results from a cross-selectional studyEmilie Sbidian, Smaïl Hadj-Rabia, Vincent M Riccardi, et al.
Medicine|January 16, 2010
Bacteremia in Stevens-Johnson syndrome and toxic epidermal necrolysis: epidemiology, risk factors, and predictive value of skin culturesNicolas de Prost, Saskia Ingen-Housz-Oro, Tu Anh Duong, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine|June 18, 2023
Topical delivery of mitogen-activated protein kinase inhibitor binimetinib prevents the development of cutaneous neurofibromas in neurofibromatosis type 1 mutant miceFanny Coulpier, Pernelle Pulh, Layna Oubrou, et al.
Melanoma Research|April 2, 2004
Cutaneous malignant melanoma and neurofibromatosis type 1Bernard Guillot, Sophie Dalac, Michele Delaunay, et al.
Dermatology (Basel, Switzerland)|April 15, 2015
Positive Direct Immunofluorescence Is of Better Value than ELISA-BP180 and ELISA-BP230 Values for the Prediction of Relapse after Treatment Cessation in Bullous Pemphigoid: A Retrospective Study of 97 PatientsSaskia Ingen-Housz-Oro, Julie Plée, Thibaut Belmondo, et al.
Pageof 23